Investegate |Immunicum AB Announcements | Immunicum AB: Immunicum to Host Investor Meeting with CEO
Investegate announcements from Immunicum AB, Immunicum to Host Investor Meeting with CEO
Stay updated with breaking news from Immunicum Ab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Immunicum AB, Immunicum to Host Investor Meeting with CEO
Press Release 30 September 2021 Immunicum Appoints New Experts in Cancer Immunology to Scientific Advisory Board Immunicum AB (publ; IMMU.ST)...
Investegate announcements from Immunicum AB, Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress
Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress -- Ongoing ADVANCE II study evaluating DCP-001 in AML patients is nearing target enrollment of 20 patients -- Immunicum AB (publ; IMMU.ST) today presents clinical data showing DCP-001’s ability to induce immune responses to a broad range of tumor associated antigens in acute myeloid leukemia (AML) patients, as well as preclinical results of enhanced efficacy when combining DCP-0
Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress -- Ongoing ADVANCE II study...